The US Court of Appeals for the Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) finding that tribal immunity does not apply to inter partes review (IPR) proceedings. Saint Regis Mohawk ...

In a precedential decision, issued June 14, 2019, the Federal Circuit affirmed the PTAB’s ruling against the University of Minnesota, declining to dismiss petitions for inter partes review (“IPR”).

Genetic testing company GeneDx has turned to the Patent Trial and Appeal Board to try and invalidate 11 of Myriad Genetics patents, in a move that underlines the increasing popularity of inter partes ...

Last week, a federal appellate court upheld on constitutional grounds a controversial procedure that has in recent years rendered thousands of patent claims invalid. In MCM Porfolio v. Hewlett-Packard ...

Policy makers in Washington are closer than ever to passing legislative reforms that have the potential to rein in the high cost of prescription drugs in the United States. Substantial obstacles ...

Most claims are being accepted for trial and Delaware seems reluctant to grant stays: Scott Alter, Walter Linder and Robert O’Loughlin explain these and other conclusions from the first year of inter ...

Update: The Supreme Court upheld so-called patent death squads in a 7-2 ruling on Tuesday, April 24. The fate of a major patent reform law, enacted in 2011 to improve patent quality, will hang in the ...